Benoît Tessoulin

3.1k total citations
79 papers, 1.2k citations indexed

About

Benoît Tessoulin is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Benoît Tessoulin has authored 79 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 28 papers in Pathology and Forensic Medicine and 24 papers in Hematology. Recurrent topics in Benoît Tessoulin's work include Lymphoma Diagnosis and Treatment (27 papers), CAR-T cell therapy research (21 papers) and Chronic Lymphocytic Leukemia Research (20 papers). Benoît Tessoulin is often cited by papers focused on Lymphoma Diagnosis and Treatment (27 papers), CAR-T cell therapy research (21 papers) and Chronic Lymphocytic Leukemia Research (20 papers). Benoît Tessoulin collaborates with scholars based in France, United States and United Kingdom. Benoît Tessoulin's co-authors include Steven Le Gouill, Philippe Moreau, Catherine Pellat‐Deceunynck, Martine Amiot, David Chiron, Sophie Maïga, Cyrille Touzeau, Géraldine Descamps, Céline Bellanger and Thomas Gastinne and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Benoît Tessoulin

71 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benoît Tessoulin France	18	516	436	365	306	244	79	1.2k
Stanley Frankel United States	13	424 0.8×	514 1.2×	211 0.6×	362 1.2×	240 1.0×	24	1.2k
Mark Bishton United Kingdom	20	507 1.0×	686 1.6×	209 0.6×	477 1.6×	214 0.9×	71	1.3k
Matthew Mei United States	20	523 1.0×	216 0.5×	286 0.8×	391 1.3×	292 1.2×	108	1.1k
Amit Khot Australia	12	299 0.6×	416 1.0×	253 0.7×	340 1.1×	253 1.0×	53	971
Xiujin Ye China	16	253 0.5×	326 0.7×	526 1.4×	161 0.5×	140 0.6×	94	984
Adriana Pleșa France	18	311 0.6×	464 1.1×	487 1.3×	157 0.5×	184 0.8×	79	1.1k
Peter Duggan Canada	18	455 0.9×	452 1.0×	841 2.3×	287 0.9×	181 0.7×	106	1.4k
Alison R. Sehgal United States	13	633 1.2×	373 0.9×	326 0.9×	174 0.6×	143 0.6×	52	1.1k
Eric Van Den Neste Belgium	23	450 0.9×	592 1.4×	299 0.8×	448 1.5×	641 2.6×	79	1.6k
Zeba N. Singh United States	15	485 0.9×	360 0.8×	497 1.4×	127 0.4×	130 0.5×	54	984

Countries citing papers authored by Benoît Tessoulin

Since Specialization

Citations

This map shows the geographic impact of Benoît Tessoulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Tessoulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Tessoulin more than expected).

Fields of papers citing papers by Benoît Tessoulin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoît Tessoulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Tessoulin. The network helps show where Benoît Tessoulin may publish in the future.

Co-authorship network of co-authors of Benoît Tessoulin

This figure shows the co-authorship network connecting the top 25 collaborators of Benoît Tessoulin. A scholar is included among the top collaborators of Benoît Tessoulin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoît Tessoulin. Benoît Tessoulin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bellanger, Céline, Christelle Dousset, Yannick Le Bris, et al.. (2026). CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival. Leukemia.

Kwiatek, Michał, Guru Subramanian Guru Murthy, Marc Hoffmann, et al.. (2025). A First-in-Human Phase I Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients With Advanced Hematologic Malignancies. Clinical Lymphoma Myeloma & Leukemia. 25(7). 512–519. 1 indexed citations

Reizine, Florian, Benoît Tessoulin, Fabrice Camou, et al.. (2025). Prognostic impact and safety of early adjunctive corticosteroid therapy in HIV-negative severe pneumocystis pneumonia: a propensity-matched multicentre study. Thorax. thorax–2025.

Cherblanc, Fanny, Fontanet Bijou, Pierre Sesques, et al.. (2025). Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials. Blood Cancer Journal. 15(1). 190–190.

Aymard, M., Morgane Cheminant, Roch Houot, et al.. (2025). Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group. Blood Advances. 10(1). 75–82.

Gouill, Steven Le, Virginie De Wilde, Toby A. Eyre, et al.. (2024). Ibrutinib, Venetoclax Plus CD20 Monoclonal Ab Provides Very High MRD Negativity in Previously Untreated MCL Patients, Initial Results of OASIS II, a Randomized Phase 2 Trial. Blood. 144(Supplement 1). 745–745. 1 indexed citations

Issa, Nahéma, Fabrice Camou, Rose‐Anne Lavergne, et al.. (2024). Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease. CHEST Journal. 165(6). 1319–1329. 14 indexed citations

Bellanger, Céline, Benoît Tessoulin, Christelle Dousset, et al.. (2024). Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma. Haematologica. 109(8). 2574–2584. 1 indexed citations

Gurion, Ronit, Catherine Thiéblemont, Won Seog Kim, et al.. (2024). Fixed-Duration Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Updated Results from Arm 1 of the Epcore NHL-5 Trial. Blood. 144(Supplement 1). 3110–3110. 7 indexed citations

10.

Schroers‐Martin, Joseph G., Jurik Mutter, Mohammad Shahrokh Esfahani, et al.. (2023). Longitudinal Noninvasive Surveillance & Fragmentomic Characterization of Follicular Lymphoma. Blood. 142(Supplement 1). 528–528.

11.

Bellanger, Céline, Yannick Le Bris, Juliana C. Santos, et al.. (2023). CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma. Blood. 142(18). 1543–1555. 11 indexed citations

12.

Descamps, Géraldine, Céline Bellanger, Christelle Dousset, et al.. (2023). A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics. Blood. 143(13). 1242–1258. 7 indexed citations

13.

Gouill, Steven Le, Franck Morschhauser, David Chiron, et al.. (2020). Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial. Blood. 137(7). 877–887. 75 indexed citations

14.

Tessoulin, Benoît, Kamal Bouabdallah, Barbara Burroni, et al.. (2020). Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA. Annals of Hematology. 99(8). 1771–1778. 9 indexed citations

15.

Tessoulin, Benoît, Géraldine Descamps, Christelle Dousset, Martine Amiot, & Catherine Pellat‐Deceunynck. (2019). Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells. Frontiers in Oncology. 9. 128–128. 24 indexed citations

16.

Descamps, Géraldine, Sophie Maïga, Benoît Tessoulin, et al.. (2017). Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells. International Journal of Molecular Sciences. 19(1). 40–40. 3 indexed citations

17.

Tessoulin, Benoît, Thomas Gastinne, Philippe Moreau, et al.. (2017). Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas. Annals of Hematology. 96(6). 943–950. 9 indexed citations

18.

Chiron, David, Céline Bellanger, Benoît Tessoulin, et al.. (2016). Regular Article LYMPHOID NEOPLASIA Microenvironment-dependent proliferation and mitochondrial priming loss in mantle cell lymphoma is overcome by anti-CD20. Blood. 2 indexed citations

19.

Bourgeois, Amandine Le, Myriam Labopin, Thierry Guillaume, et al.. (2014). Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults. Experimental Hematology. 42(11). 945–954. 11 indexed citations

20.

Tessoulin, Benoît, J. Delaunay, Patrice Chevallier, et al.. (2014). Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT. Bone Marrow Transplantation. 49(4). 567–571. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact